Cardiovascular Devices Market by Device Type, Indication, End-User - Global Forecast 2025-2030- Product Image

Sale

Cardiovascular Devices Market by Device Type, Indication, End-User - Global Forecast 2025-2030

Report
191 Pages
October 2024
Region: Global
360iResearch™
ID: 5336858

UP TO €688EUR$697USD£574GBP OFF until Dec 31^st 2024

The Cardiovascular Devices Market grew from USD 53.69 billion in 2023 to USD 57.55 billion in 2024. It is expected to continue growing at a CAGR of 7.38%, reaching USD 88.40 billion by 2030.

The cardiovascular devices market encompasses a wide array of equipment and technologies used to diagnose, monitor, and treat heart and blood-related disorders. The scope of this market covers diagnostic imaging systems, surgical procedures, and implantable devices like pacemakers and stents. These devices are crucial due to the high prevalence of cardiovascular diseases (CVDs) globally, driven by aging populations, sedentary lifestyles, and unhealthy diets. The market is segmented by applications like coronary intervention, peripheral intervention, and cardiovascular surgery, with end-users mainly being hospitals, diagnostic labs, and ambulatory surgery centers. Key growth factors include technological advancements, increasing healthcare expenditure, and rising awareness about early diagnosis and treatment of CVDs. Emerging opportunities lie in minimally invasive technologies and wireless monitoring solutions, driven by the need for more patient-friendly and cost-effective healthcare options. Strategic recommendations include investing in R&D for innovative device designs and leveraging AI and IoT for better diagnostics and remote monitoring capabilities. However, market expansion faces challenges such as stringent regulatory approvals, high costs of advanced devices, and inadequate healthcare infrastructure in developing regions. One major limitation is the dependency on skilled professionals for device operation, which limits accessibility. Therefore, training programs and workshops can help mitigate this issue. For innovation, focusing on personalized medicine and developing devices compatible with wearable technology can lead to significant advancements. Additionally, research into biodegradable stents and new drug-eluting technologies offers further avenues for growth. The market is competitive yet evolving, with a blend of established players and new entrants driving dynamic shifts. Companies that successfully navigate regulatory requirements while addressing cost and accessibility concerns will likely set the standard, making adaptability a crucial attribute in this sector.

Understanding Market Dynamics in the Cardiovascular Devices Market

The Cardiovascular Devices Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.

Market Drivers
- Increasing burden of cardiovascular diseases
- Rising preference for minimally invasive procedures
- Improved healthcare facilities and the expanding reach of healthcare services in emerging economies
Market Restraints
- Stringent regulatory policies and product recalls
Market Opportunities
- Integration of wearable technology for continuous monitoring of heart health
- Ongoing research in the biocompatibility and material science of cardiovascular device
Market Challenges
- Limited number of reimbursement policies

Exploring Porter’s Five Forces for the Cardiovascular Devices Market

Porter’s Five Forces framework further strengthens the insights of the Cardiovascular Devices Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Cardiovascular Devices Market

External macro-environmental factors deeply influence the performance of the Cardiovascular Devices Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Cardiovascular Devices Market

The Cardiovascular Devices Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Cardiovascular Devices Market

The Cardiovascular Devices Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Cardiovascular Devices Market

The Cardiovascular Devices Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cardiovascular Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, ACS Diagnostics, Alivecor, Inc., Asahi Kasei Corporation, B. Braun SE, Baxter International Inc., Bexen Medical, Biotronik SE & Co KG, Boston Scientific Corporation, BPL Medical Technologies Private Limited, GE Healthcare, HeartFlow Holding, Inc., Johnson & Johnson Services, Inc., Koninklijke Philips N.V.,, Lepu Medical Technology(Beijing)Co., Ltd., LivaNova PLC, Medtronic PLC, Microport Scientific Corporation, Nihon Kohden Corporation, Qardio, Inc., Schiller AG, Terumo Medical Corporation, Tricog Health, Vesalius Cardiovascular Inc., and Zoll Medical Corporation.

Market Segmentation & Coverage

This research report categorizes the Cardiovascular Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

Device Type
- Diagnostic & Monitoring Devices
  - Blood Pressure Monitors
  - Cardiac CT & MRI Scanners
  - Electrocardiogram Devices
  - Holter Monitors
  - Remote Cardiac Monitoring
  - Stress Test Systems
- Therapeutic & Surgical Devices
  - Artificial Hearts
  - Cardiac Ablation Catheters
  - Coronary Guidewires
  - Heart Monitors
  - Heart Valves
  - Implantable Cardioverter Defibrillators
  - Pacemakers
  - Stents
  - Ventricular Assist Devices
Indication
- Cardiac Arrhythmia
- Coronary Artery Disease
- Heart Failure
- Peripheral Arterial Disease
End-User
- Ambulatory Surgical Centers
- Hospitals
- Specialty Clinics

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

What is the current size of the market, and how is it expected to grow?
Which products, segments, and regions present the most attractive investment opportunities?
What are the prevailing technology trends and regulatory factors influencing the market?
How do top vendors rank regarding market share and competitive positioning?
What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
4. Market Overview

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing burden of cardiovascular diseases
5.1.1.2. Rising preference for minimally invasive procedures
5.1.1.3. Improved healthcare facilities and the expanding reach of healthcare services in emerging economies
5.1.2. Restraints
5.1.2.1. Stringent regulatory policies and product recalls
5.1.3. Opportunities
5.1.3.1. Integration of wearable technology for continuous monitoring of heart health
5.1.3.2. Ongoing research in the biocompatibility and material science of cardiovascular device
5.1.4. Challenges
5.1.4.1. Limited number of reimbursement policies
5.2. Market Segmentation Analysis
5.2.1. Device Type: Burgeoning adoption of blood pressure monitors essential for diagnosing and managing hypertension
5.2.2. End-User: Evolving utilization of cardiovascular devices across the ambulatory surgical centers
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental

6. Cardiovascular Devices Market, by Device Type

6.1. Introduction
6.2. Diagnostic & Monitoring Devices
6.2.1. Blood Pressure Monitors
6.2.2. Cardiac CT & MRI Scanners
6.2.3. Electrocardiogram Devices
6.2.4. Holter Monitors
6.2.5. Remote Cardiac Monitoring
6.2.6. Stress Test Systems
6.3. Therapeutic & Surgical Devices
6.3.1. Artificial Hearts
6.3.2. Cardiac Ablation Catheters
6.3.3. Coronary Guidewires
6.3.4. Heart Monitors
6.3.5. Heart Valves
6.3.6. Implantable Cardioverter Defibrillators
6.3.7. Pacemakers
6.3.8. Stents
6.3.9. Ventricular Assist Devices

7. Cardiovascular Devices Market, by Indication

7.1. Introduction
7.2. Cardiac Arrhythmia
7.3. Coronary Artery Disease
7.4. Heart Failure
7.5. Peripheral Arterial Disease

8. Cardiovascular Devices Market, by End-User

8.1. Introduction
8.2. Ambulatory Surgical Centers
8.3. Hospitals
8.4. Specialty Clinics

9. Americas Cardiovascular Devices Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Cardiovascular Devices Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Cardiovascular Devices Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Johnson & Johnson Acquires Shockwave Medical for USD 13.1 Billion, Bolstering Its Cardiovascular Care Offerings
12.3.2. Medtronic and Cardiac Design Labs Unveil Revolutionary External Loop Recorder Technology in India
12.3.3. InfoBionic's MoMe ARC Receives FDA Approval for Revolutionizing Cardiac Monitoring
12.4. Strategy Analysis & Recommendation

List of Figures

FIGURE 1. CARDIOVASCULAR DEVICES MARKET RESEARCH PROCESS
FIGURE 2. CARDIOVASCULAR DEVICES MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 9. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 11. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. CARDIOVASCULAR DEVICES MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. CARDIOVASCULAR DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

List of Tables

TABLE 1. CARDIOVASCULAR DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. CARDIOVASCULAR DEVICES MARKET DYNAMICS
TABLE 7. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY BLOOD PRESSURE MONITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY CARDIAC CT & MRI SCANNERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY ELECTROCARDIOGRAM DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY HOLTER MONITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY REMOTE CARDIAC MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY STRESS TEST SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY ARTIFICIAL HEARTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY CARDIAC ABLATION CATHETERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY CORONARY GUIDEWIRES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY HEART MONITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY HEART VALVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY PACEMAKERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY STENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY CARDIAC ARRHYTHMIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY CORONARY ARTERY DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY HEART FAILURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 42. ARGENTINA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 43. ARGENTINA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 44. ARGENTINA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 45. ARGENTINA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 46. ARGENTINA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 47. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 48. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 49. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 50. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 52. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 53. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 54. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 55. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 56. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 57. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 58. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 59. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 60. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 61. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 68. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 69. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 70. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 71. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 72. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 73. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 74. AUSTRALIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 75. AUSTRALIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 76. AUSTRALIA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 77. AUSTRALIA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 78. AUSTRALIA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 79. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 80. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 81. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 82. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 83. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 84. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 85. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 86. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 87. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 88. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 89. INDONESIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 90. INDONESIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 91. INDONESIA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 92. INDONESIA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 93. INDONESIA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 94. JAPAN CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 95. JAPAN CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 96. JAPAN CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 97. JAPAN CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 98. JAPAN CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 99. MALAYSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 100. MALAYSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 101. MALAYSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 102. MALAYSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 103. MALAYSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 104. PHILIPPINES CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 105. PHILIPPINES CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 106. PHILIPPINES CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 107. PHILIPPINES CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 108. PHILIPPINES CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 109. SINGAPORE CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 110. SINGAPORE CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 111. SINGAPORE CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 112. SINGAPORE CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 113. SINGAPORE CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 114. SOUTH KOREA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 115. SOUTH KOREA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 116. SOUTH KOREA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 117. SOUTH KOREA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 118. SOUTH KOREA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 119. TAIWAN CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 120. TAIWAN CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 121. TAIWAN CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 122. TAIWAN CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 123. TAIWAN CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 124. THAILAND CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 125. THAILAND CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 126. THAILAND CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 127. THAILAND CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 128. THAILAND CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 129. VIETNAM CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 130. VIETNAM CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 131. VIETNAM CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 132. VIETNAM CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 133. VIETNAM CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 140. DENMARK CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 141. DENMARK CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 142. DENMARK CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 143. DENMARK CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 144. DENMARK CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 145. EGYPT CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 146. EGYPT CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 147. EGYPT CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 148. EGYPT CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 149. EGYPT CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 150. FINLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 151. FINLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 152. FINLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 153. FINLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 154. FINLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 155. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 156. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 157. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 158. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 159. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 160. GERMANY CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 161. GERMANY CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 162. GERMANY CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 163. GERMANY CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 164. GERMANY CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 165. ISRAEL CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 166. ISRAEL CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 167. ISRAEL CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 168. ISRAEL CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 169. ISRAEL CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 170. ITALY CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 171. ITALY CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 172. ITALY CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 173. ITALY CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 174. ITALY CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 175. NETHERLANDS CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 176. NETHERLANDS CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 177. NETHERLANDS CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 178. NETHERLANDS CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 179. NETHERLANDS CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 180. NIGERIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 181. NIGERIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 182. NIGERIA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 183. NIGERIA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 184. NIGERIA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 185. NORWAY CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 186. NORWAY CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 187. NORWAY CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 188. NORWAY CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 189. NORWAY CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 190. POLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 191. POLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 192. POLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 193. POLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 194. POLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 195. QATAR CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 196. QATAR CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 197. QATAR CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 198. QATAR CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 199. QATAR CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 200. RUSSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 201. RUSSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 202. RUSSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 203. RUSSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 204. RUSSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 205. SAUDI ARABIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 206. SAUDI ARABIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 207. SAUDI ARABIA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 208. SAUDI ARABIA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 209. SAUDI ARABIA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 210. SOUTH AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 211. SOUTH AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 212. SOUTH AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 213. SOUTH AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 214. SOUTH AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 215. SPAIN CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 216. SPAIN CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 217. SPAIN CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 218. SPAIN CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 219. SPAIN CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 220. SWEDEN CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 221. SWEDEN CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 222. SWEDEN CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 223. SWEDEN CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 224. SWEDEN CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 225. SWITZERLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 226. SWITZERLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 227. SWITZERLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 228. SWITZERLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 229. SWITZERLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 230. TURKEY CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 231. TURKEY CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 232. TURKEY CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 233. TURKEY CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 234. TURKEY CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 235. UNITED ARAB EMIRATES CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 236. UNITED ARAB EMIRATES CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 237. UNITED ARAB EMIRATES CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 238. UNITED ARAB EMIRATES CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 239. UNITED ARAB EMIRATES CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 240. UNITED KINGDOM CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 242. UNITED KINGDOM CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 244. UNITED KINGDOM CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 245. CARDIOVASCULAR DEVICES MARKET SHARE, BY KEY PLAYER, 2023
TABLE 246. CARDIOVASCULAR DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Cardiovascular Devices Market, which are profiled in this report, include:

Abbott Laboratories
ACS Diagnostics
Alivecor, Inc.
Asahi Kasei Corporation
B. Braun SE
Baxter International Inc.
Bexen Medical
Biotronik SE & Co KG
Boston Scientific Corporation
BPL Medical Technologies Private Limited
GE Healthcare
HeartFlow Holding, Inc.
Johnson & Johnson Services, Inc.
Koninklijke Philips N.V.,
Lepu Medical Technology(Beijing)Co., Ltd.
LivaNova PLC
Medtronic PLC
Microport Scientific Corporation
Nihon Kohden Corporation
Qardio, Inc.
Schiller AG
Terumo Medical Corporation
Tricog Health
Vesalius Cardiovascular Inc.
Zoll Medical Corporation

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	191
Published	October 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 57.55 Billion
Forecasted Market Value ( USD ) by 2030	$ 88.4 Billion
Compound Annual Growth Rate	7.3%
Regions Covered	Global
No. of Companies Mentioned	25

License	Format	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access		This is a single user license, allowing one user access to the product.	€3502EUR$3,545USD£2,918GBP €3891EUR$3,939USD£3,243GBP
ENTERPRISE LICENSE PDF, Excel and Online Access		This is an enterprise license, allowing all employees within your organization access to the product.	€6195EUR$6,272USD£5,163GBP €6883EUR$6,969USD£5,737GBP

Understanding Market Dynamics in the Cardiovascular Devices Market

Exploring Porter’s Five Forces for the Cardiovascular Devices Market

Applying PESTLE Analysis to the Cardiovascular Devices Market

Analyzing Market Share in the Cardiovascular Devices Market

Evaluating Vendor Success with the FPNV Positioning Matrix in the Cardiovascular Devices Market

Strategic Recommendations for Success in the Cardiovascular Devices Market

Key Company Profiles

Market Segmentation & Coverage

The report provides a detailed overview of the market, exploring several key areas:

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

United States Cardiovascular Devices Market, Size, Share, Forecast 2024-2030, Industry Trends, Growth, Insight, Top Companies Analysis

Cardiovascular Devices - Global Strategic Business Report

Cardiovascular Repair & Reconstruction Devices Market by Product, Application, End-use - Global Forecast 2025-2030

Cardiovascular Surgery Devices Market by Product Type, Procedure Type, End User - Global Forecast 2025-2030

Electrophysiology Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

About the Cardiovascular Devices Market